SKP2 and cancer: Although this crosstalk mechanism occurs in a cellular context different from that of cell cycle regulation, it provides a molecular basis to account for the antitumor effects of ERMAs by upregulating β-TrCP-mediated apoptosis signaling in cancer cells with aberrant Skp2 expression.